Page last updated: 2024-08-23

colforsin and 9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2h-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester

colforsin has been researched along with 9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2h-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bohn, LM; Partilla, JS; Prisinzano, TE; Rothman, RB; Rutherford, JM; Tidgewell, K; Wang, X; Xu, H1

Other Studies

1 other study(ies) available for colforsin and 9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2h-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester

ArticleYear
A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Synapse (New York, N.Y.), 2007, Volume: 61, Issue:3

    Topics: Analgesics, Opioid; Animals; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Drug Tolerance; Endocytosis; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Furans; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Narcotic Antagonists; Opioid-Related Disorders; Pyrones; Radioligand Assay; Receptors, Opioid, mu

2007